The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of a new concept cancer vaccine composed artificial intelligence (AI)-designed shared-antigen peptides plus combined synergistically activating antigen-specific CTL reaction (CYT001) in patients with advanced hepatocellular carcinoma (CRESCENT 1).
 
Sadahisa Ogasawara
Honoraria - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; Lilly; Lilly; Lilly; Lilly
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Eisai; Eisai; Eisai; Eisai; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Research Funding - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai
 
Hiroaki Kanzaki
No Relationships to Disclose
 
Keisuke Koroki
No Relationships to Disclose
 
Kengo Kanayama
No Relationships to Disclose
 
Susumu Maruta
No Relationships to Disclose
 
Kazufumi Kobayashi
No Relationships to Disclose
 
Souichiro Kiyono
No Relationships to Disclose
 
Masato Nakamura
No Relationships to Disclose
 
Naoya Kanogawa
No Relationships to Disclose
 
Takayuki Kondo
No Relationships to Disclose
 
Eiichiro Suzuki
No Relationships to Disclose
 
Yoshihiko Ooka
No Relationships to Disclose
 
Shingo Nakamoto
No Relationships to Disclose
 
Akinobu Tawada
No Relationships to Disclose
 
Tetsuhiro Chiba
No Relationships to Disclose
 
Makoto Arai
No Relationships to Disclose
 
Hiroyuki Nakada
No Relationships to Disclose
 
Nobuko Yamaguchi
No Relationships to Disclose
 
Hideki Hanaoka
No Relationships to Disclose
 
Naoya Kato
Honoraria - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; Merck; Merck; Merck; Merck; Sumitomo Group; Sumitomo Group; Sumitomo Group; Sumitomo Group
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai
Research Funding - Bayer; Bayer; Bayer; Bayer; CYTLIMIC; CYTLIMIC; CYTLIMIC; CYTLIMIC; Eisai; Eisai; Eisai; Eisai